Brief: Glycomimetics Inc -On June 21, Got Notice From Nasdaq, Co Is Not In Compliance With Nasdaq’S Listing Rule 5450(A)(1)
26/06/2024 21:35
GlycoMimetics Inc GLYC.O :
* GLYCOMIMETICS INC -ON JUNE 21, GOT NOTICE FROM NASDAQ, CO
IS NOT
IN COMPLIANCE WITH NASDAQ’S LISTING RULE 5450(A)(1)
Source text for Eikon: ID:n0001558370-24-009508
Further company coverage: GLYC.O
Recent news on Crescent Biopharma
See all newsBrief: Crescent Biopharma - Potential To Initiate First CR-001 Phase 3 Study In Early 2028
Brief: Crescent Biopharma Announces FDA Clearance Of Ind Application For CR-002, A Pd-L1-Targeted Topoisomerase Inhibitor Adc, For The Treatment Of Solid Tumors
Crescent Biopharma posts smaller-than-expected Q2 net loss
U.S. STOCKS ON THE MOVE-Cintas, Veradermics
Crescent Biopharma slips on $125 mln share offering